Blood-Based Alzheimer’s Tests Are Here, but Not Ready for Widespread Use
While new FDA clearances of blood-based early detection tests for Alzheimer’s represent significant progress, limitations remain.
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article